The prevalence of diabetes in the U.S.
continues to rise by epidemic proportions.
This increase parallels the
rising rates of obesity and overweight observed
over the past decade (1,2). Indeed,
as BMI increases, the risk of developing
type 2 diabetes increases in a “dosedependent”
manner (3,4). The prevalence
of type 2 diabetes is 3–7 times higher in
obese than in normal-weight adults, and
those with a BMI 35 kg/m2 are 20 times
more likely to develop diabetes than those
with a BMI between 18.5 and 24.9 kg/m2